CAS NO: | 848416-07-9 |
包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 | Lascufloxacin (KRP-AM1977X) is a potent and orally active fluoroquinolone antibacterial agent. Lascufloxacin potently inhibits infections caused by various pathogens, including quinolone-resistant strains. Lascufloxacin has the potential for various infectious diseases treatment, including lower respiratory tract infections[1][2]. | |
IC50& Target |
| |
体外研究 (In Vitro) | In the Gram-negative bacteria, Lascufloxacin shows antibacterial activities againstMoraxella catarrhalisand β-lactamase-negative ampicillin-susceptible and ampicillin-resistant strains ofHaemophilus influenzae, with an MIC90value of 0.06 μg/mL in all cases. The MIC90values againstEnterobacter spp.,Klebsiella pneumoniae, andAcinetobacter spp.are 0.25 μg/mL, 0.25 μg/mL, and 0.5 μg/mL, respectively. Lascufloxacin inhibitsE. coliandP. aeruginosawith MIC90s of 0.25 μg/mL and 4 μg/mL, respectively. The MIC50and MIC90values of Lascufloxacin againstM. pneumoniaeare 0.12 μg/mL and 0.25 μg/mL, respectively. Lascufloxacin shows potent activity against macrolide-resistantM. pneumoniaeisolates with an MIC90of 0.12 μg/mL[1]. | |
体内研究 (In Vivo) | A pharmacodynamic study using a mouse thigh infection model indicates that the ratios of the free area under the curve (fAUC) to MIC in plasma required for bacteriostasis, or 1-log or 2-log CFU killing againstS. pneumoniaeisolates, are 10, 16, and 28, respectively. Lascufloxacin shows significant bacterial killing in the mouse model when emulated the area under the concentration-time curve (AUC) in plasma in dose of 75 mg per day [q.d.])[2]. | |
分子量 | 439.43 | |
Formula | C21H24F3N3O4 | |
CAS 号 | 848416-07-9 | |
运输条件 | Room temperature in continental US; may vary elsewhere. | |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |